Cell Line Development Services Market Overview The cell line development services market is projected to be worth $1.5 billion and is likely to reach up to $5.3 billion by 2030, representing a CAGR of nearly 13.7%. Over the years, the biopharmaceutical market has grown into a promising, high value vertical within the overall pharmaceutical industry. In fact, nearly 29% and 25% of the total number of novel drugs approved by the Food and Drug Administration’s Center for Drug Evaluation an
...read moreAAV Based Gene Therapy, AAV Manufacturing and AAV Technology Market Overview The global AAV vector market (AAV based gene therapy and AAV manufacturing) is projected to grow from USD 1.9 billion in 2022 to USD 11.1 billion by 2035, exhibiting a CAGR of 14% during the forecast period. Given the potential of gene therapies in targeting the underlying cause of a disease at cellular level, the demand for such therapies has increased considerably over the past few years. Currently, more
...read moreBlood-Brain Barrier Market The revenues of blood-brain barrier (BBB) penetrant products are projected to grow up to $940 million by 2030, representing a CAGR of 154% during the forecast period. According to a study conducted by the World Health Organization (WHO), diseases that affect the central nervous system (CNS), such as Alzheimer’s disease, brain cancer, multiple sclerosis. Parkinson’s disease and stroke, are characterized by a significant unmet need for effective treat
...read moreCell Free System Overview The global cell free expression market is estimated to be USD 275 million in 2023 and is anticipated to grow at a CAGR of 7.5% till 2035. In recent years, cell free systems / cell free expression systems have emerged as a promising alternative for the conventional cell based biomanufacturing process. It is a well-known fact that traditional biomanufacturing is a complex process that requires living cells and specific conditions in order to maintain pro
...read moreBuffer Preparation Market Overview The global buffer preparation systems market is anticipated to grow at a CAGR of around 5.9%, till 2035. Buffers are aqueous solutions used to control pH in drug manufacturing process and are a vital component in maintaining the stability of both biologics and small molecules during production and in their final form. Moreover, buffers are used in multiple upstream and downstream bioprocesses for various applications, including maintaining the stable pH of c
...read moreNanoparticle Formulation Market Overview The global nanoparticle formulation market was estimated to be worth USD 5.1 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9.4% during the forecast period. Over the years, nanoparticles have emerged as a versatile drug delivery system for the controlled, targeted delivery of therapeutics for the treatment of several diseases. Owing to their inherent properties, such as small size, multifunctional behavior and surfac
...read moreConjugation and Labeling Services Market Overview The global conjugation and labeling services market is estimated to be worth $0.9 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 10.2% during the forecast period. Conjugation is the process of formation of a single, stable hybrid, wherein one of the entities is a molecule, such as protein, antibody, peptide and small molecule. These molecules can be conjugated with various modalities, such as haptens, e
...read moreBispecific Antibody Therapeutics Market Overview The global bispecific antibodies market is estimated to be worth $5.6 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9.5% during the forecast period. Bispecific antibodies (BsAbs) represent a novel class of antibodies that act by simultaneously attaching to two separate / distinct antigens or different epitopes of the same antigen. These drugs primarily function by redirecting immune effector cells to ef
...read moreLab Automation Overview The global lab automation market is estimated to be worth $5.5 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9.3% during the forecast period. Owing to the growing demand for complex biopharmaceuticals, the number of laboratories providing analytical and product development solutions has increased significantly across the globe. During each step of a laboratory process, it is essential to ensure that all the variables and parame
...read moreCannabis Testing Overview The global cannabis testing market was valued at USD 1.72 billion in 2023 and is anticipated to grow at a CAGR of 22.8% during the forecast period 2023-2035. In the last few years, several countries across the globe have legalized the use of medical cannabis and recreational / adult use cannabis. This can be attributed to the therapeutic potential of cannabis and cannabis-infused products that has been acknowledged recently. Studies have shown that cannabis can provi
...read moreVirtual Clinical Trials Market Overview The global virtual clinical trials market size is estimated to be USD 4.2 billion in 2023 and is anticipated to grow at a compounded annual growth rate (CAGR) of 13% over the forecast period 2023-2035. The development of a novel molecular entity, for pharmacological use, is complex as well as cost intensive. It requires close to 10 years and over USD 2.5 billion in capital investment for a prescription therapeutic to traverse from bench to the market. I
...read moreAntibiotics Market Overview The global antibiotics market was estimated to be worth USD 36 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 1.2% during the forecast period. Bacterial infections are known to be one of the leading causes of deaths, worldwide. In fact, infections caused by bacteria are responsible for every one out of eight deaths, globally. This can be attributed to the fact that majority of the pathogenic bacteria have developed resistance aga
...read morePharmaceutical Polymers / Medical Polymers Market Overview The global pharmaceutical polymers / medical polymers market is estimated to be worth USD 20 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 7.3% during the forecast period 2023-2035. Polymers represent a versatile class of materials composed of multiple simple chemical units, commonly known as monomers. Polymers are classified as natural and synthetic polymers based on raw materials. Some examp
...read moreGene Switch / Molecular Switch Overview The global gene switch / molecular switch market is estimated to be USD 670 million in 2023 and is anticipated to grow at a CAGR of 11.5% during the forecast period. Driven by numerous developmental breakthroughs and encouraging clinical trial results demonstrating the vast potential of adoptive cell therapy, including CAR T cell therapy, TCR therapy, TIL and natural killer cell therapy, this therapeutic modality has garnered considerable attention from
...read moreDigital Transformation In Biologic Manufacturing Overview The global digital manufacturing market for biologics is anticipated to grow at a compounded annual growth rate (CAGR) of 18% during the forecast period, driven mainly by the increased focus on industry 4.0 technologies. Digital transformation has also garnered the interest of pharmaceutical industry. It involves incorporating digital technologies across all functions / operations. Digital technologies have been impacting drug discover
...read moreOral Solid Dosage Manufacturing Overview Oral solid dosage contract manufacturing market is estimated to be USD 21 billion in 2023 and is anticipated to grow at a CAGR of ~5% during the forecast period. Over the years, rising complexity of active pharmaceutical ingredients (APIs) has led to the development of a myriad of novel formulations that enable efficient drug delivery to the intended site of action. Nonetheless, the demand for oral solid dosage (OSD) forms, including tablets and c
...read moreFiltration Market Overview The global filtration market is estimated to be worth $5.1 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9.0% during the forecast period. Biologics represents one of the fastest growing segments of the healthcare sector. In last five years, over 50 biologics been approved by the Food and Drug Administration (FDA) and close to 10,000 biologics are being evaluated across different stages of development. The growing demand for
...read moreAseptic Fill Finish Manufacturing Market Overview The aseptic fill finish manufacturing market is estimated to be worth USD 5.4 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9%, during the forecast period. Aseptic fill finish refers to accurate and sterile fill finish / sealing of drug products into packaging containers, such as vials, prefilled syringes, ampoules and cartridges. These aseptic conditions during fill-finish operations are not only esse
...read moreFermenters And Bioreactors Market Overview The global fermenters and bioreactors market was estimated to be worth USD 20.4 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 11.3% during the forecast period. Since their introduction in 1982, biologics have gained popularity owing to their therapeutic efficacy, favorable safety profiles, and the ability to treat a wide variety of disease indications, which are otherwise hard to treat. In fact, in the past two de
...read moreLow drug solubility and its corresponding impact on bioavailability have remained a primary cause of concern with several marketed as well as clinical stage drugs. According to the Journal of Analytical and Pharmaceutical Research, 70% of the 50 drugs approved by the USFDA in 2021 were poorly soluble. Moreover, approximately 40% of marketed pharmacological products and close to 90% of drug candidates under development, have been associated with solubility and / or permeability issues, resulting
...read moreCHOOSE CATEGORY
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES